Using Both Clinical Registry and Administrative Claims Data to Measure Risk-adjusted Surgical Outcomes

Elise H Lawson1, Rachel Louie, David S Zingmond

  • 1*Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA †Division of Research and Optimal Patient Care, American College of Surgeons, Chicago, IL ‡VA Greater Los Angeles Healthcare System, Los Angeles, CA §Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA ¶RAND Corporation, Santa Monica, CA ||UCLA Jonathan and Karin Fielding School of Public Health, Los Angeles, CA **Department of Surgery, School of Medicine, Washington University in St Louis, and Barnes Jewish Hospital, St Louis, MO ††Center for Health Policy and the Olin Business School at Washington University in St Louis, St Louis, MO ‡‡Department of Surgery, John Cochran Veterans Affairs Medical Center, St Louis, MO §§BJC Healthcare, St Louis, MO.

Annals of Surgery
|November 19, 2014
PubMed
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
587
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
857
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.6K
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
387